Cancer-Drug Maker Loses 2nd Bid To Duck Stock-Drop Suit

A California federal judge on Tuesday rejected a biotechnology company's request to dismiss an updated securities fraud lawsuit against it over allegedly misleading results in a clinical trial for its cancer...

Already a subscriber? Click here to view full article